Brief: Alzinova Confirms Positive Phase 1B Results With Alz-101 Against Alzheimer's
Jan 30 (Reuters) - Alzinova AB ALZ.ST :
* ALZINOVA: PRIMARY ANALYSIS CONFIRMS POSITIVE PHASE 1B
RESULTS
WITH ALZ-101 AGAINST ALZHEIMER’S
* EXTENSION PART OF STUDY CONTINUES IN 2024 WITH EXPECTED
RESULTS
IN FIRST HALF OF 2025
Source text for Eikon: ID:nMFN1mBZ4p
Further company coverage: ALZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Alzinova AB
See all newsBrief: Alzinova's Board Resolves On Directed Issue Of Units
Brief: Alzinova Announces Preliminary Outcome Of The Rights Issue
Brief: Alzinova Broadens Shareholder Base With New Investor
Brief: Alzinova Resolves On Rights Issue Of SEK 51 Mln
Brief: Alzinova Q2 Loss After Financial Items At SEK 5.4 Million